GUAIFENESIN 600 MG
Generic: GUAIFENESIN
Strategic Sourcing ServicesManufacturer
ORALRoute
GUAIFENESINActive Substance
2022-03-15Original Approval
GUAIFENESIN 600 MG is FDA application ANDA215932, sponsored by DR REDDYS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2025-01-07
Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI PharmaceuticalSuperpotent; sodium benzoate preservative
Class II2017-12-12
Codeine-Guaifenesin Oral Solution 10-100 mg/5 mL Antitussive Expectorant ,16 fl. oz. , Manufactured For: Method PharmaceMicrobial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkhol
Top Reported Reactions
1
DYSPNOEA
679 reports
2
DRUG INEFFECTIVE
647 reports
3
PNEUMONIA
630 reports
4
NAUSEA
602 reports
5
FATIGUE
576 reports
6
DIARRHOEA
572 reports
7
PAIN
499 reports
8
HEADACHE
469 reports
9
COUGH
468 reports
10
OFF LABEL USE
437 reports